The University of Chicago Header Logo

Connection

Richard Whitley to Vidarabine

Back to Details
This is a "connection" page, showing publications Richard Whitley has written about Vidarabine.
Richard Whitley
Connection Strength
2.314
Vidarabine
  1. Commentary: Ch'ien LT, Cannon NJ, Charamella LJ, et al. effect of adenine arabinoside on severe herpesvirus hominis infections in man: preliminary report. J Infect Dis 1973; 128:658-63. J Infect Dis. 2004 Oct 01; 190(7):1360-7.
    View in: PubMed
    Score: 0.245
  2. Neonatal herpes simplex virus infections: pathogenesis and therapy. Pathol Biol (Paris). 1992 Sep; 40(7):729-34.
    View in: PubMed
    Score: 0.106
  3. Disseminated herpes zoster in the immunocompromised host: a comparative trial of acyclovir and vidarabine. The NIAID Collaborative Antiviral Study Group. J Infect Dis. 1992 Mar; 165(3):450-5.
    View in: PubMed
    Score: 0.102
  4. Natural history and treatment of varicella-zoster in high-risk populations. J Hosp Infect. 1991 Jun; 18 Suppl A:317-29.
    View in: PubMed
    Score: 0.097
  5. A controlled trial comparing vidarabine with acyclovir in neonatal herpes simplex virus infection. Infectious Diseases Collaborative Antiviral Study Group. N Engl J Med. 1991 Feb 14; 324(7):444-9.
    View in: PubMed
    Score: 0.095
  6. Herpes simplex virus infections of the central nervous system. A review. Am J Med. 1988 Aug 29; 85(2A):61-7.
    View in: PubMed
    Score: 0.080
  7. Antiviral treatment of a serious herpes simplex infection: encephalitis. J Am Acad Dermatol. 1988 Jan; 18(1 Pt 2):209-11.
    View in: PubMed
    Score: 0.077
  8. Factors indicative of outcome in a comparative trial of acyclovir and vidarabine for biopsy-proven herpes simplex encephalitis. Infection. 1987; 15 Suppl 1:S3-8.
    View in: PubMed
    Score: 0.071
  9. Vidarabine versus acyclovir therapy in herpes simplex encephalitis. N Engl J Med. 1986 Jan 16; 314(3):144-9.
    View in: PubMed
    Score: 0.067
  10. High-pressure liquid chromatographic methods for determining arabinosyladenine-5'-monophosphate, arabinosyladenine, and arabinosylhypoxanthine in plasma and urine. Antimicrob Agents Chemother. 1985 Aug; 28(2):265-73.
    View in: PubMed
    Score: 0.065
  11. Neonatal herpes: what have we learned. Semin Pediatr Infect Dis. 2005 Jan; 16(1):7-16.
    View in: PubMed
    Score: 0.062
  12. Therapeutic challenges of neonatal herpes simplex virus infection. Scand J Infect Dis Suppl. 1985; 47:97-106.
    View in: PubMed
    Score: 0.062
  13. Effect of adenine arabinoside on severe Herpesvirus hominis infections in man. 1973. J Infect Dis. 2004 Oct 01; 190(7):1362-7.
    View in: PubMed
    Score: 0.061
  14. Therapeutic approaches to the control of cytomegalovirus infections. Birth Defects Orig Artic Ser. 1984; 20(1):345-52.
    View in: PubMed
    Score: 0.058
  15. Vidarabine therapy for mucocutaneous herpes simplex virus infections in the immunocompromised host. J Infect Dis. 1984 Jan; 149(1):1-8.
    View in: PubMed
    Score: 0.058
  16. Neonatal herpes simplex virus infection: follow-up evaluation of vidarabine therapy. Pediatrics. 1983 Dec; 72(6):778-85.
    View in: PubMed
    Score: 0.058
  17. Interim summary of mortality in herpes simplex encephalitis and neonatal herpes simplex virus infections: vidarabine versus acyclovir. J Antimicrob Chemother. 1983 Sep; 12 Suppl B:105-12.
    View in: PubMed
    Score: 0.057
  18. Early vidarabine therapy to control the complications of herpes zoster in immunosuppressed patients. N Engl J Med. 1982 Oct 14; 307(16):971-5.
    View in: PubMed
    Score: 0.053
  19. Vidarabine therapy of varicella in immunosuppressed patients. J Pediatr. 1982 Jul; 101(1):125-31.
    View in: PubMed
    Score: 0.052
  20. Antiviral agents: clinical status report. Hosp Pract (Off Ed). 1981 Jul; 16(7):109-21.
    View in: PubMed
    Score: 0.049
  21. Herpes simplex encephalitis: vidarabine therapy and diagnostic problems. N Engl J Med. 1981 Feb 05; 304(6):313-8.
    View in: PubMed
    Score: 0.047
  22. Vidarabine: a preliminary review of its pharmacological properties and therapeutic use. Drugs. 1980 Oct; 20(4):267-82.
    View in: PubMed
    Score: 0.046
  23. Vidarabine therapy of neonatal herpes simplex virus infection. Pediatrics. 1980 Oct; 66(4):495-501.
    View in: PubMed
    Score: 0.046
  24. Herpes simplex encephalitis: need for accurate diagnosis. JAMA. 1980 Jul 25; 244(4):371-2.
    View in: PubMed
    Score: 0.046
  25. Plasma levels and urinary excretion of vidarabine after repeated dosing. Clin Pharmacol Ther. 1980 May; 27(5):690-6.
    View in: PubMed
    Score: 0.045
  26. Distribution of adenine arabinoside and interferon. JAMA. 1979 Sep 21; 242(12):1259-60.
    View in: PubMed
    Score: 0.043
  27. Developmental aspects of adenine arabinoside for parenteral therapy of human herpesvirus infections. Adv Ophthalmol. 1979; 38:288-96.
    View in: PubMed
    Score: 0.041
  28. Adenine arabinoside therapy of biopsy-proved herpes simplex encephalitis. J Med Assoc State Ala. 1977 Sep; 47(3):37-42, 66.
    View in: PubMed
    Score: 0.037
  29. Adenine arabinoside therapy of biopsy-proved herpes simplex encephalitis. National Institute of Allergy and Infectious Diseases collaborative antiviral study. N Engl J Med. 1977 Aug 11; 297(6):289-94.
    View in: PubMed
    Score: 0.037
  30. Adenine arabinoside therapy of herpes zoster in the immunosuppressed. NIAID collaborative antiviral study. N Engl J Med. 1976 May 27; 294(22):1193-9.
    View in: PubMed
    Score: 0.034
  31. Diagnosis of herpes simplex encephalitis: application of polymerase chain reaction to cerebrospinal fluid from brain-biopsied patients and correlation with disease. National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. J Infect Dis. 1995 Apr; 171(4):857-63.
    View in: PubMed
    Score: 0.032
  32. Neonatal herpes simplex virus infections: is there a role for immunoglobulin in disease prevention and therapy? Pediatr Infect Dis J. 1994 May; 13(5):432-8; discussion 438-9.
    View in: PubMed
    Score: 0.030
  33. Antiviral therapy: the time has come. J Med Virol. 1993; Suppl 1:1.
    View in: PubMed
    Score: 0.027
  34. Therapeutic approaches to varicella-zoster virus infections. J Infect Dis. 1992 Aug; 166 Suppl 1:S51-7.
    View in: PubMed
    Score: 0.026
  35. Neonatal herpes simplex virus infections. Presentation and management. J Reprod Med. 1986 May; 31(5 Suppl):426-32.
    View in: PubMed
    Score: 0.017
  36. Therapy for human herpesvirus infections. A perspective. Ala J Med Sci. 1985 Apr; 22(2):193-207.
    View in: PubMed
    Score: 0.016
  37. Treatment of human herpesvirus infections with special reference to encephalitis. J Antimicrob Chemother. 1984 Aug; 14 Suppl A:57-74.
    View in: PubMed
    Score: 0.015
  38. Prophylactic or anticipatory antiviral therapy for newborns exposed to herpes simplex infection. Pediatr Infect Dis. 1984 May-Jun; 3(3):193-5.
    View in: PubMed
    Score: 0.015
  39. Towards therapy and prevention of herpetic infections. Semin Perinatol. 1983 Jan; 7(1):64-81.
    View in: PubMed
    Score: 0.014
  40. Repeated suppression of Creutzfeldt-Jakob disease with vidarabine. Lancet. 1982 Sep 04; 2(8297):564-5.
    View in: PubMed
    Score: 0.013
  41. Herpes simplex encephalitis and clinical trial design. Lancet. 1982 May 01; 1(8279):1013.
    View in: PubMed
    Score: 0.013
  42. Herpesvirus infections in childhood: diagnostic dilemmas and therapy. Pediatr Infect Dis. 1982 Mar-Apr; 1(2):81-4.
    View in: PubMed
    Score: 0.013
  43. Preventive and therapeutic approaches to the newborn infant with perinatal viral and toxoplasma infections. Clin Perinatol. 1981 Oct; 8(3):591-604.
    View in: PubMed
    Score: 0.012
  44. Current status of antiviral chemotherapy. South Med J. 1978 Sep; 71(9):1134-40.
    View in: PubMed
    Score: 0.010
  45. NIH conference. Herpes zoster-varicella infections in immunosuppressed patients. Ann Intern Med. 1978 Sep; 89(3):375-88.
    View in: PubMed
    Score: 0.010
  46. Treatment of infections due to Herpesvirus in humans: a critical review of the state of the art. J Infect Dis. 1976 Jun; 133 Suppl:A101-8.
    View in: PubMed
    Score: 0.009
  47. Adenine arabinoside for therapy of herpes zoster in immunosuppressed patients: preliminary results of a collaborative study. J Infect Dis. 1976 Jun; 133 Suppl:A184-91.
    View in: PubMed
    Score: 0.009
  48. Therapy of herpetic infections in man: a status report. Adv Pathobiol. 1976; (5):159-72.
    View in: PubMed
    Score: 0.008
  49. Antiviral chemotherapy and neonatal herpes simplex virus infecition: a pilot study--experience with adenine arabinoside (ARA-A). Pediatrics. 1975 May; 55(5):678-85.
    View in: PubMed
    Score: 0.008
  50. Neonatal herpes simplex virus infection. Int Ophthalmol Clin. 1975; 15(4):141-9.
    View in: PubMed
    Score: 0.008
  51. Difference between herpes simplex virus type 1 and type 2 neonatal encephalitis in neurological outcome. Lancet. 1988 Jan 2-9; 1(8575-6):1-4.
    View in: PubMed
    Score: 0.005
  52. Experience with brain biopsy for suspected herpes encephalitis: a review of forty consecutive cases. Neurosurgery. 1983 Jun; 12(6):654-7.
    View in: PubMed
    Score: 0.003
  53. Serum antibody levels as risk factors in the dissemination of herpes zoster. Arch Intern Med. 1979 Dec; 139(12):1341-5.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.